Lung Cancer Oncology

Treatment-free interval as a determinant of second-line chemotherapy outcomes in extensive-stage small cell lung cancer: a Dutch population-based study

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →